IP Verse

Nad-Augmentation Therapy For Parkinson'S Disease

Patent No. EP4284387 (titled "Nad-Augmentation Therapy For Parkinson'S Disease") was filed by Vestlandets Innovasjonsselskap VIS on Jun 24, 2022. The application was issued on Jul 31, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IMMUNOPHARMAApr 29, 2025WEICKMANN & WEICKMANN PARTMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4284387

VESTLANDETS INNOVASJONSSELSKAP VIS
Application Number
EP22740800A
Filing Date
Jun 24, 2022
Status
Granted And Under Opposition
Jun 27, 2024
Publication Date
Jul 31, 2024
External Links
Slate, Register , Google Patents